Skip to main content
. 2017 May 2;42(7):1894–1903. doi: 10.1007/s11064-017-2275-z

Fig. 4.

Fig. 4

Pharmacoresistance epilepsy work flow for the Epilepsy Therapy Screening Program (ETSP)